Global Non-Invasive Prenatal Testing Market High Demand, Recent Trends, Future Growth, Industry Analysis, Forecasts Rese

Comments · 383 Views

The global non-invasive prenatal testing market is forecasted to grow at a rate of 13.9% in terms of value, from USD 3.08 billion in 2019 to reach USD 8.75 billion by 2027. Advantages connected with the usage of these experiments as contributing to a substantial decrease in the amount of c

A new market assessment report on Global Non-Invasive Prenatal Testing Market brings to light a detailed statistics on the dramatic shift in the competitive landscape and business environment of the Global Non-Invasive Prenatal Testing Market for the forecast period 2020 - 2027. The comprehensive study offers an overview of the current state of development of the business as well as predicts the course of progress across different regions. A large number of factors including the major driving forces, threats and opportunities are taken into account to present an analytical picture of the industry portrayed in the report. 

Read more@ https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

Segments Covered in the report

Method Outlook (Revenue, USD Billion; 2017-2027)

Ultrasound Detection

Biochemical Screening Tests

Cell-free DNA in Maternal Plasma Tests

Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)

Diagnostic Laboratories

Hospitals

Research Centers

Clinics

Application Outlook (Revenue, USD Billion; 2017-2027)

Trisomy

Microdeletion Syndrome

Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

North America

Europe

Asia Pacific

MEA

Latin America

You Can Download Free Sample PDF Copy of Global Non-Invasive Prenatal Testing Market at https://www.emergenresearch.com/request-sample/16

The key highlight:

In April 2019, Progenity Inc. confirmed the introduction of the Resura Prenatal Test, a non-invasive, personalized prenatal check for monogenetic diseases.

In February 2019, Invitae Corporation confirmed the extension of the company's women's genetic testing programs by providing non-invasive prenatal screening (NIPS) to provide access to accessible prenatal genetic testing.

In August 2018, Sema4 introduced Sema4 Noninvasive Prenatal Select and updated the corporation's Expanded Carrier Monitor for non-invasive fetal monitoring.

In April 2017, Illumina Inc. introduced VeriSeq NIPT Solution, which allows non-invasive prenatal testing in-house laboratories in Europe.

Competitive Landscape

Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc. have been profiled in the report. They are the major manufacturers of the product.

Table of Content

Chapter 1. Market Synopsis

Chapter 2. Executive Summary

Chapter 3. Indicative Metrics

Chapter 4. Non-Invasive Prenatal Testing Market Segmentation Impact Analysis

Chapter 5. Non-Invasive Prenatal Testing Market By Method Insights Trends

Chapter 6. Non-Invasive Prenatal Testing Market By End-Use Insights Trends

Chapter 7. Non-Invasive Prenatal Testing Market By Application Insights Trends

Chapter 8. Non-Invasive Prenatal Testing Market Regional Outlook

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

Comments